4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Abstract The American College of Cardiology Foundation in collaboration with the Heart
Rhythm Society and key specialty and subspecialty societies conducted a review of common …

Background The subcutaneous implantable cardioverter–defibrillator (ICD) was designed to
avoid complications related to the transvenous ICD lead by using an entirely extrathoracic …

4. Delivery of care and ensuring access to care.............. e108 4.1. Recommendations for the
coordination and delivery of care for adults with CHD and arrhythmias …

Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …

Background The implantable cardioverter–defibrillator (ICD) is highly effective in reducing
mortality among patients at risk for fatal arrhythmias, but inappropriate ICD activations are …

There is an increasing proportion of the general population surviving to old age with
significant chronic disease, multi-morbidity, and disability. The prevalence of pre-frail state …

Background—The most frequent complications associated with implantable cardioverter-
defibrillators (ICDs) involve the transvenous leads. A subcutaneous implantable cardioverter …

Aims The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the
conventional transvenous ICD system to minimize intravascular lead complications. There …

Importance Using more intervals to detect ventricular tachyarrhythmias has been associated
with reducing unnecessary implantable cardioverter-defibrillator (ICD) therapies. Objective …